Recent BioUtah News & Events

The Utah Pavilion will serve as a gathering place to help convention attendees discover the state’s vibrant life sciences industry and the sector’s unique culture of collaboration that drives innovation.

The designation follows encouraging Phase 2 clinical trial results.

Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases.

Visit has included tour of Utah headquarters and automated manufacturing facilities ahead of planned technology transfer.

First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs.

The study, published in the Journal of Arthroplasty, highlighted that the Company’s NeuroCuple® Nanotechnology Device achieved statistically significant reduction in opioid use.

Build It Live at the HITLAB World Cup.

The DSMB review was conducted as part of the pre-planned clinical safety oversight process agreed upon with the U.S. FDA.

New 75,000-square-foot facility to open in October 2026 near Salt Lake City International Airport, extending company’s national reach for medical device manufacturers

The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping

nView medical announced that its nView s1 system has surpassed 1,000 surgeries, marking an important milestone in the clinical use of the company’s intraoperative 3D imaging and navigation technology.

University of Utah Launchpad Seed Fund award to support translational validation of NanoKar’s ITAM optimization platform, including CAR-T persistence and activity in solid tumor models.

Expanded collaboration adds manufacturing capacity, strengthens redundancy, and supports later-stage development planning for Ratio’s lead FAP-targeted radiotherapeutic candidate.

New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence

Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally

Mosman to lead NanoKar’s next phase of translational validation, partner readiness, and strategic collaboration for its ITAM optimization platform

Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s most competitive annual programs

Recent pathogens illustrate need for improved situational awareness capabilities, such as those provided by the Co-Dx PCR point-of-care platform

Funds will fuel sales team expansion and broader market access, advancing the company’s leadership in Implantable Tibial Neuromodulation (ITNM) for the treatment of urgency urinary incontinence (UUI)

351-patient trial completion marks a key milestone for the Celeste® program; topline data to be presented May 26 in Phoenix

FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker data

VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term benefit on complications associated with achondroplasia

Two ARUP Medical Directors Receive Career Achievement Awards

As gaps in early detection persist, a 45-second voice analysis offers a new way to identify signals of stress, anxiety, and depression during Mental Health Awareness Month

What to Know About the Reauthorized SBIR/STTR Grant Programs

H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity

Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026

Freyya Wins San Antonio TechFuel 2026 Competition

Apr 14, 2026 University of Utah Health dedicated the James LeVoy Sorenson Center for Medical Innovation, a $50-million world-class hub designed to accelerate transformative research, medical device development, and life science training. Made possible by a generous $22 million lead gift from the Sorenson Legacy Foundation, the state-of-the-art facility serves as the new heart of […]

James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting

PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan